<p>MK801-induced immobility and swimming time in C57BL/6N mice (A,B) and in mice lacking NMDAR specifically in PV neurons (PV-Cre+/NR1f/f, <i>red bars</i>) compared with control (NR1f/f, <i>black bars</i>) (C,D). (A) Immobility of C57BL/6N mice in repeated FST 30 min, 24 h and 1 week after acute treatment with 0.1 mg/kg MK801 (<i>white bars</i>, n = 10) or water (<i>black bars</i>, n = 10). MK801 induces rapid antidepressant-like responses to a lesser extent than ketamine 30 min after treatment. The antidepressant effect of MK801 is abolished 24 h and 1 week after treatment. MK801-induced immobility time is: 220±3 water and 171±17 MK801 (30 min) (p<0.05 Student's t-test); 224±5 water and 223±3 MK801 (24 h) (p>0.05 Student's t-test); 197±10 ...
The underlying circuit imbalance in major depression remains unknown and current therapies remain in...
The tail suspension test is a behavioural primary screen for detecting potential antidepressant drug...
Lamotrigine is an anticonvulsant agent that shows clinical antidepressant properties. The aim of the...
We tested fluoxetine, bupropion and GR 205171, a selective neurokinin-1 receptor antagonist on force...
<p>(A) The chemical structure of M084. (B&C) M084 reduced immobility time in forced swim test (FST, ...
164-170L-arginine-nitric oxide (NO)-cyclic guanosine monophosphate (cGMP) is an important signaling ...
<p>Immobility of mice lacking NMDAR specifically in PV interneurons (PV-Cre+/NR1f/f,<i>red bars</i>)...
<p><b>A.</b> In a forced swim test GluD1 KO (n = 13) displayed a greater duration of immobility comp...
It has been reported that lead can cause behavioral impairment by inhibiting the N-methyl-D-aspartat...
Topiramate (TPM) is an agent primarily used in the treatment of epilepsy. Using mice model of forced...
The Forced Swim Test (FST) is a rodent behavioral paradigm utilized for assessment of potential anti...
Low dose acute administration of N-methyl-D-aspartate receptor (NMDAR) antagonist MK-801 is widely u...
<p>A: Immobility time in a forced swimming test was measured 2, 4 and 6 weeks after TAC surgery. B: ...
PubMedID: 15006455Recent findings have indicated that nitric oxide (NO) may change the duration of i...
Kynurenic acid (KYNA) is an L-tryptophan metabolite with neuromodulatory activities, regulating the ...
The underlying circuit imbalance in major depression remains unknown and current therapies remain in...
The tail suspension test is a behavioural primary screen for detecting potential antidepressant drug...
Lamotrigine is an anticonvulsant agent that shows clinical antidepressant properties. The aim of the...
We tested fluoxetine, bupropion and GR 205171, a selective neurokinin-1 receptor antagonist on force...
<p>(A) The chemical structure of M084. (B&C) M084 reduced immobility time in forced swim test (FST, ...
164-170L-arginine-nitric oxide (NO)-cyclic guanosine monophosphate (cGMP) is an important signaling ...
<p>Immobility of mice lacking NMDAR specifically in PV interneurons (PV-Cre+/NR1f/f,<i>red bars</i>)...
<p><b>A.</b> In a forced swim test GluD1 KO (n = 13) displayed a greater duration of immobility comp...
It has been reported that lead can cause behavioral impairment by inhibiting the N-methyl-D-aspartat...
Topiramate (TPM) is an agent primarily used in the treatment of epilepsy. Using mice model of forced...
The Forced Swim Test (FST) is a rodent behavioral paradigm utilized for assessment of potential anti...
Low dose acute administration of N-methyl-D-aspartate receptor (NMDAR) antagonist MK-801 is widely u...
<p>A: Immobility time in a forced swimming test was measured 2, 4 and 6 weeks after TAC surgery. B: ...
PubMedID: 15006455Recent findings have indicated that nitric oxide (NO) may change the duration of i...
Kynurenic acid (KYNA) is an L-tryptophan metabolite with neuromodulatory activities, regulating the ...
The underlying circuit imbalance in major depression remains unknown and current therapies remain in...
The tail suspension test is a behavioural primary screen for detecting potential antidepressant drug...
Lamotrigine is an anticonvulsant agent that shows clinical antidepressant properties. The aim of the...